Axsome Therapeutics, Inc. (AXSM)

NASDAQ: AXSM · Real-Time Price · USD

233.64

+3.02 (1.31%)

At close: May 21, 2026, 4:00 PM EDT

235.39

+1.75 (0.75%)

After-hours: May 21, 2026, 7:50 PM EDT

Axsome Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	305.11	322.93	315.35	386.19	200.84	86.47
Cash & Short-Term Investments	305.11	322.93	315.35	386.19	200.84	86.47
Cash Growth	1.39%	2.40%	-18.34%	92.29%	132.26%	-52.97%
Accounts Receivable	251.06	224.46	142	94.82	37.7	-
Inventory	31.52	27.94	15.73	15.14	4.32	-
Other Current Assets	23.52	13.65	11.98	8.12	2.78	0.05
Total Current Assets	611.21	588.99	485.06	504.26	245.64	86.52
Net Property, Plant & Equipment	20.58	21.42	5.97	7.62	1.14	0.94
Other Intangible Assets	38.95	40.52	46.89	53.29	59.66	-
Goodwill	12.04	12.04	12.04	12.04	10.31	-
Other Long-Term Assets	30.83	26.84	18.53	11.03	14.72	0.32
Total Assets	713.61	689.81	568.5	588.24	331.48	87.79
Accounts Payable	106.7	65.54	72	40.68	38.61	13.15
Accrued Expenses	250.73	232.85	147.99	90.5	51.63	9.3
Short-Term Debt	70	70	-	-	-	-
Current Portion of Leases	0.63	0.43	1.84	1.27	0.43	0.62
Other Current Liabilities	11.15	10.01	8.29	6.41	5.9	-
Total Current Liabilities	439.21	378.84	230.1	138.85	96.56	23.07
Long-Term Debt	117.85	117.75	180.71	178.07	94.26	49.09
Long-Term Leases	28.23	27.39	8.99	7.04	-	-
Other Long-Term Liabilities	73.73	77.54	91.68	73.3	31.1	-
Total Long-Term Liabilities	219.81	222.67	281.38	258.41	125.36	49.09
Total Liabilities	659.02	601.51	511.48	397.26	221.92	72.15
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-in Capital	1,425	1,394	1,180	1,027	705.89	424.83
Retained Earnings	-1,371	-1,306	-1,123	-835.57	-596.33	-409.2
Shareholders' Equity	54.59	88.3	57.02	190.98	109.56	15.63
Total Liabilities & Equity	713.61	689.81	568.5	588.24	331.48	87.79
Total Debt	216.71	215.57	191.53	186.37	94.68	49.71
Net Cash (Debt)	88.4	107.37	123.82	199.82	106.16	36.76
Net Cash Growth	-17.66%	-13.29%	-38.04%	88.23%	188.77%	-72.51%
Net Cash Per Share	1.76	2.16	2.58	4.40	2.61	0.98
Book Value	54.59	88.3	57.02	190.98	109.56	15.63
Book Value Per Share	1.08	1.77	1.19	4.20	2.69	0.42
Tangible Book Value	3.6	35.73	-1.92	125.65	39.59	15.63
Tangible Book Value Per Share	0.07	0.72	-0.04	2.77	0.97	0.42

Updated May 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q